Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00905177 · ClinicalTrials.gov registry record
Predictors of Anticoagulation Control on Warfarin Therapy
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 687
- Enrollment target
NCT00905177: Completed study, sponsored by University of Pennsylvania.
NCT00905177 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 687 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00905177 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 687 participants
- Enrollment target
Study Summary
The goal of this research study is to develop better dosing of anticoagulation medication in both Caucasian and African Americans through analysis of various genetic factors.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 687 participants |
| Start Date | 2009-06 |
| Est. Completion | 2013-08 |
What the finished NCT00905177 record still lists
NCT00905177 is an observational study that tracks outcomes without assigning an intervention. The registered 687 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00905177 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00905177 about?
NCT00905177 is a clinical study titled "Predictors of Anticoagulation Control on Warfarin Therapy". The goal of this research study is to develop better dosing of anticoagulation medication in both Caucasian and African Americans through analysis of various genetic factors.
What is the current status of trial NCT00905177?
This trial is currently completed. The enrollment target is 687 participants. The study started on 2009-06. Estimated completion is 2013-08.
Who is sponsoring clinical trial NCT00905177?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05750654 · 688 participants · NA
Effectiveness of Small Phlebotomy Tubes in Reducing Blood Transfusions in Adult Medical Intensive Care Unit and Intermediate Care Unit Patients With Anemia
- NCT04333537 · 686 participants · Phase 2
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
- NCT06459180 · 686 participants · Phase 3
A Study to Compare Sacituzumab Tirumotecan (MK-2870) Monotherapy Versus Treatment of Physician's Choice as Second-line Treatment for Participants With Recurrent or Metastatic Cervical Cancer (MK-2870-020/TroFuse-020/Gog-3101/ENGOT-cx20)
- NCT06618274 · 686 participants · NA
Effectiveness of Central Oncology Navigation and the Use of an ORN
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia